CN1094756C - 解热镇痛组合药剂 - Google Patents

解热镇痛组合药剂 Download PDF

Info

Publication number
CN1094756C
CN1094756C CN94194929A CN94194929A CN1094756C CN 1094756 C CN1094756 C CN 1094756C CN 94194929 A CN94194929 A CN 94194929A CN 94194929 A CN94194929 A CN 94194929A CN 1094756 C CN1094756 C CN 1094756C
Authority
CN
China
Prior art keywords
ibuprofen
isopropylantipyrine
layer
granules
lozenge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94194929A
Other languages
English (en)
Chinese (zh)
Other versions
CN1142766A (zh
Inventor
藤津隆
米田喜久子
池边勇夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26416787&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1094756(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of CN1142766A publication Critical patent/CN1142766A/zh
Application granted granted Critical
Publication of CN1094756C publication Critical patent/CN1094756C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN94194929A 1993-12-10 1994-12-02 解热镇痛组合药剂 Expired - Fee Related CN1094756C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP310803/93 1993-12-10
JP31080393 1993-12-10
JP75638/94 1994-04-14
JP7563894 1994-04-14

Publications (2)

Publication Number Publication Date
CN1142766A CN1142766A (zh) 1997-02-12
CN1094756C true CN1094756C (zh) 2002-11-27

Family

ID=26416787

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94194929A Expired - Fee Related CN1094756C (zh) 1993-12-10 1994-12-02 解热镇痛组合药剂

Country Status (13)

Country Link
US (1) US5686109A (enExample)
EP (1) EP0812589B1 (enExample)
JP (1) JP3168582B2 (enExample)
KR (1) KR100347631B1 (enExample)
CN (1) CN1094756C (enExample)
AT (1) ATE195418T1 (enExample)
DE (1) DE69425589T2 (enExample)
DK (1) DK0812589T3 (enExample)
ES (1) ES2148470T3 (enExample)
GR (1) GR3034434T3 (enExample)
PT (1) PT812589E (enExample)
TW (1) TW279799B (enExample)
WO (1) WO1995015751A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US6812985B1 (en) 1996-09-23 2004-11-02 Lg.Philips Lcd Co., Ltd. Liquid crystal display device
KR100251512B1 (ko) 1997-07-12 2000-04-15 구본준 횡전계방식 액정표시장치
JP4828707B2 (ja) * 2000-02-28 2011-11-30 武田薬品工業株式会社 固形圧縮製剤
ATE330586T1 (de) * 2001-03-14 2006-07-15 Pfizer Prod Inc Pharmazeutische tablette und eine verfahren zu deren herstellung
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
JP2003095944A (ja) * 2001-09-27 2003-04-03 Kowa Co 鎮痛剤
FR2855756B1 (fr) * 2003-06-06 2005-08-26 Ethypharm Sa Comprime orodispersible multicouche
KR101125268B1 (ko) * 2003-06-06 2012-04-23 에띠팜 구강 분산성 다중층 정제
EP1755564B1 (en) * 2004-05-21 2013-10-16 Accu-Break Technologies, Inc. Immediate release pharmaceutical tablets with height greater than width
BRPI0520797B8 (pt) * 2005-11-18 2021-05-25 Accu Break Tech Inc forma de dosagem farmacêutica comprimida em bicamadas
US8202538B2 (en) * 2006-06-26 2012-06-19 Capricorn Pharma, Inc. Orally disintegrating layered compositions
EP2049089A4 (en) * 2006-08-08 2012-07-04 Accu Break Technologies Inc PHARMACEUTICAL TABLETS WITH SEVERAL ACTIVE SEGMENTS
EP2070520A1 (en) 2007-12-11 2009-06-17 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media
JP2013121948A (ja) * 2011-11-07 2013-06-20 Daiichi Sankyo Healthcare Co Ltd 眠気が改善された感冒薬
JP6307874B2 (ja) * 2012-12-27 2018-04-11 大正製薬株式会社 レイヤリング粒子
JP7419057B2 (ja) * 2019-12-27 2024-01-22 ライオン株式会社 錠剤及びコーティング錠

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5697224A (en) * 1979-12-28 1981-08-05 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
JPS61134315A (ja) * 1984-12-05 1986-06-21 Taisho Pharmaceut Co Ltd 解熱鎮痛剤
JPH0228111A (ja) * 1988-06-01 1990-01-30 Merrell Dow Pharmaceut Inc ピペリジノアルカノール‐イブプロフェン組み合わせに対する製剤組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS609752B2 (ja) * 1979-11-09 1985-03-12 東邦新薬株式会社 新規な２−アセトキシベンズアミド誘導体、その製法及びそれを有効成分とする医薬
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
GB8623557D0 (en) * 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents
EP0497977B1 (en) * 1989-10-26 1995-03-15 Nippon Shinyaku Company, Limited Gastric preparation
US5213807A (en) * 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin
CA2107678A1 (en) * 1991-04-08 1992-10-09 Kouichi Nakamichi Capsule
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5697224A (en) * 1979-12-28 1981-08-05 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
JPS61134315A (ja) * 1984-12-05 1986-06-21 Taisho Pharmaceut Co Ltd 解熱鎮痛剤
JPH0228111A (ja) * 1988-06-01 1990-01-30 Merrell Dow Pharmaceut Inc ピペリジノアルカノール‐イブプロフェン組み合わせに対する製剤組成物

Also Published As

Publication number Publication date
JP3168582B2 (ja) 2001-05-21
EP0812589B1 (en) 2000-08-16
PT812589E (pt) 2000-11-30
US5686109A (en) 1997-11-11
DE69425589D1 (de) 2000-09-21
KR960706335A (ko) 1996-12-09
EP0812589A4 (en) 1999-06-23
CN1142766A (zh) 1997-02-12
GR3034434T3 (en) 2000-12-29
EP0812589A1 (en) 1997-12-17
WO1995015751A1 (en) 1995-06-15
DK0812589T3 (da) 2000-11-13
ES2148470T3 (es) 2000-10-16
KR100347631B1 (ko) 2002-11-29
TW279799B (enExample) 1996-07-01
DE69425589T2 (de) 2001-01-04
ATE195418T1 (de) 2000-09-15

Similar Documents

Publication Publication Date Title
CN1319518C (zh) 具有改进的生物利用率的液体药物口服药物剂型
CN1211086C (zh) 雷诺嗪持续释放制剂
CN1227004C (zh) 治疗充血性心力衰竭的部分脂肪酸氧化抑制剂
CN1255185C (zh) 无定形甲磺酸奈非那韦的药物剂型
CN1126533C (zh) 有机组合物的改进或有关有机组合物的改进
CN1250371A (zh) 用于控制释放活性物质的药物组合物
CN1399543A (zh) 含有尼美舒利的控释组合物
CN1277535C (zh) 布洛芬活性成分制剂
CN1301534A (zh) 稳定的缓释口服给药组合物
CN1089471A (zh) 稳定的延长释放口服组合物
CN88101104A (zh) 药物片剂、药物粒剂及其制备方法
CN1339972A (zh) 在口腔中迅速崩解的片剂
CN1856321A (zh) 降钙素在骨关节炎中的用途
CN1031183A (zh) 二氢吡啶贮存制剂
CN1726028A (zh) 固体口服剂型药物
CN1142766A (zh) 解热镇痛组合药剂
CN1633281A (zh) 口内崩解的伐地考昔组合物
CN1606438A (zh) 5ht4部分激动剂药物组合物
CN1993112A (zh) 用于具有高度pH依赖性溶解度的活性成分的控释的药物多层片剂
CN1219132A (zh) 前列腺素i衍生物缓释制剂
CN1095665C (zh) 改性释放2－甲基－5－硝基－1－咪唑基－乙醇组合物及其制备和使用方法
CN1133006A (zh) 含有一种药物/β-环糊精配合物并且结合一种酸碱对的药物组合物
CN1092959C (zh) 包含噻加宾或其药学上可接受的盐的药物组合物和其制备方法
CN1205931C (zh) 包含苯甲酰胺衍生物作为活性成分的药物制剂
CN1321084A (zh) 含有布洛芬和多潘立酮的药用组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee